0001209191-17-046029.txt : 20170721 0001209191-17-046029.hdr.sgml : 20170721 20170721200721 ACCESSION NUMBER: 0001209191-17-046029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17977416 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-19 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CRO Common Stock 2017-07-19 4 M 0 20000 77.31 A 119335 D Common Stock 2017-07-19 4 S 0 20000 161.00 D 99335 D Common Stock 2017-07-21 4 S 0 800 158.05 D 98535 D Common Stock 2017-07-21 4 S 0 1300 158.90 D 97235 D Common Stock 2017-07-21 4 S 0 500 160.04 D 96735 D Common Stock 2017-07-21 4 S 0 4461 161.44 D 92274 D Common Stock 2017-07-21 4 S 0 1564 162.07 D 90710 D Common Stock 882 I 401(k) Stock Option 77.31 2017-07-19 4 M 0 20000 0.00 A 2024-02-04 Common Stock 20000 21250 D Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $158.05 (range $157.48 to $158.37). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $158.90 (range $158.61 to $159.53). Open market sales reported on this line occurred at a weighted average price of $160.04 (range $159.64 to $160.25). Open market sales reported on this line occurred at a weighted average price of $161.44 (range $160.90 to $161.89) Open market sales reported on this line occurred at a weighted average price of $162.07 (range $161.90 to $162.43). The option vests in 16 quarterly installments from 02/05/2014. Omar White, Attorney-In-Fact 2017-07-21